|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Orchard Therapeutics (NASDAQ: ORTX) through any online brokerage.
The latest price target for Orchard Therapeutics (NASDAQ: ORTX) was reported by JP Morgan on March 2, 2021. The analyst firm set a price target for 15.00 expecting ORTX to rise to within 12 months (a possible 209.28% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Orchard Therapeutics (NASDAQ: ORTX) is $4.85 last updated Today at 8:00:02 PM.
There are no upcoming dividends for Orchard Therapeutics.
There is no upcoming split for Orchard Therapeutics.
Orchard Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.